# Fluorescence Guided Resection of Brain Tumors

> **NCT00870779** · PHASE1 · COMPLETED · sponsor: **David W. Roberts** · enrollment: 105 (actual)

## Conditions studied

- Brain Tumors

## Interventions

- **DRUG:** 5-aminolevulinic acid

## Key facts

- **NCT ID:** NCT00870779
- **Lead sponsor:** David W. Roberts
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-05
- **Primary completion:** 2012-07-02
- **Final completion:** 2013-07-02
- **Target enrollment:** 105 (ACTUAL)
- **Last updated:** 2019-06-14

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00870779

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00870779, "Fluorescence Guided Resection of Brain Tumors". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT00870779. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*